Efficacy and tolerability of the Subcutaneous Semaglutide for type 2 Diabetes patients: an updated systematic review and meta-analysis

OBJECTIVES: To update and assess the efficacy and tolerability of once weekly subcutaneous semaglutide in patients with type 2 diabetes (T2D). MATERIALS AND METHODS: PubMed, Science Direct, Cochrane Library, Clinical trial, Springer, OVID, China National Knowledge Infrastructure (CNKI), WanFang Data...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Shanshan, Su, Xiaorong, Fan, Guorong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612199/
https://www.ncbi.nlm.nih.gov/pubmed/37891683
http://dx.doi.org/10.1186/s13098-023-01195-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612199/
https://www.ncbi.nlm.nih.gov/pubmed/37891683
http://dx.doi.org/10.1186/s13098-023-01195-7

Ejemplares similares